H79TI085782
Project Grant
Overview
Grant Description
Kentucky Opioid Response Effort - Guided by the Recovery-Oriented System-of-Care framework, the Kentucky (KY) Opioid Response Effort (KORE) will implement a robust array of evidence-based prevention, harm reduction, treatment, and recovery support services for individuals with opioid and/or stimulant use disorder (OUD/STIMUD).
Priority populations include:
1) Overdose survivors
2) Justice-involved individuals
3) Pregnant/parenting women
4) Black, Indigenous, and People of Color
Goals and annual objectives are driven by a needs assessment and strategic plan.
The prevention goal is to decrease OUD and STIMUD by implementing evidence-based initiatives addressing behaviors that may lead to a use disorder or overdose. Objectives include implementing evidence-based programming to 220,000 children, adolescents, and transition-aged youth; supporting 75 hospitals in implementing opioid stewardship standards; and supporting 14 regional prevention centers to increase drug take-back and safe drug storage/disposal.
The harm reduction goal is to reduce overdose fatalities and other negative impacts of opioid and stimulant use through the expansion of harm reduction strategies and principles. Objectives include distributing 58,316 naloxone units and 275,000 fentanyl test strips alongside overdose education; utilizing partnering agencies to deliver risk reduction training/resources to community partners; expanding the capacity of 40 syringe service programs to deliver harm reduction services; and delivering anti-stigma campaigns prioritizing inclusive and diverse representations of recovery.
The treatment goal is to increase equitable availability and accessibility of evidence-based treatment that includes the use of FDA-approved medications for opioid use disorder (MOUD). Objectives include supporting 13 Quick Response Teams to provide outreach, engagement, and service linkages for at least 1,200 persons who experience an overdose; expanding programs in 25 hospitals to provide buprenorphine inductions and care navigation to 2,000 persons with OUD or STIMUD; providing 500 justice-involved individuals with MOUD; providing MOUD and behavioral health services to 1,200 persons in primary care clinics; supporting four mobile MOUD programs to expand treatment capacity and availability for 250 at-risk Kentuckians; serving 600 individuals through treatment linkages and retention services delivered by recovery coaches; providing MOUD and recovery supports to 500 pregnant/parenting women; reducing barriers for 450 individuals with OUD for residential treatment and 800 individuals for methadone treatment without payment options; providing re-entry services for 500 individuals following incarceration; and supporting at least ten BIPOC-led agencies to increase utilization of harm reduction and MOUD services.
The recovery goal is to increase the number of individuals with a history of OUD and/or STIMUD who enter and remain in remission and recovery. Annual objectives include delivering recovery support services to 2,000 individuals through 12 recovery community centers and to serve 1,000 individuals through the Access to Recovery program; providing funding and fidelity support for 100 Oxford House model residences; certifying 25 recovery residences to comply with quality recovery housing standards; providing employment supports to 1,500 individuals with OUD/STIMUD; and supporting the delivery of at least 60 weekly mutual aid groups inclusive of individuals taking MOUD.
Overall, KY proposes to serve 103,200 individuals in year 1 and 184,800 in year 2, for an unduplicated total of 288,000 individuals over the course of the grant. Through the 2022 SOR, KORE will reduce overdose death as well as unmet harm reduction, treatment, and recovery support needs in the Commonwealth of KY.
Priority populations include:
1) Overdose survivors
2) Justice-involved individuals
3) Pregnant/parenting women
4) Black, Indigenous, and People of Color
Goals and annual objectives are driven by a needs assessment and strategic plan.
The prevention goal is to decrease OUD and STIMUD by implementing evidence-based initiatives addressing behaviors that may lead to a use disorder or overdose. Objectives include implementing evidence-based programming to 220,000 children, adolescents, and transition-aged youth; supporting 75 hospitals in implementing opioid stewardship standards; and supporting 14 regional prevention centers to increase drug take-back and safe drug storage/disposal.
The harm reduction goal is to reduce overdose fatalities and other negative impacts of opioid and stimulant use through the expansion of harm reduction strategies and principles. Objectives include distributing 58,316 naloxone units and 275,000 fentanyl test strips alongside overdose education; utilizing partnering agencies to deliver risk reduction training/resources to community partners; expanding the capacity of 40 syringe service programs to deliver harm reduction services; and delivering anti-stigma campaigns prioritizing inclusive and diverse representations of recovery.
The treatment goal is to increase equitable availability and accessibility of evidence-based treatment that includes the use of FDA-approved medications for opioid use disorder (MOUD). Objectives include supporting 13 Quick Response Teams to provide outreach, engagement, and service linkages for at least 1,200 persons who experience an overdose; expanding programs in 25 hospitals to provide buprenorphine inductions and care navigation to 2,000 persons with OUD or STIMUD; providing 500 justice-involved individuals with MOUD; providing MOUD and behavioral health services to 1,200 persons in primary care clinics; supporting four mobile MOUD programs to expand treatment capacity and availability for 250 at-risk Kentuckians; serving 600 individuals through treatment linkages and retention services delivered by recovery coaches; providing MOUD and recovery supports to 500 pregnant/parenting women; reducing barriers for 450 individuals with OUD for residential treatment and 800 individuals for methadone treatment without payment options; providing re-entry services for 500 individuals following incarceration; and supporting at least ten BIPOC-led agencies to increase utilization of harm reduction and MOUD services.
The recovery goal is to increase the number of individuals with a history of OUD and/or STIMUD who enter and remain in remission and recovery. Annual objectives include delivering recovery support services to 2,000 individuals through 12 recovery community centers and to serve 1,000 individuals through the Access to Recovery program; providing funding and fidelity support for 100 Oxford House model residences; certifying 25 recovery residences to comply with quality recovery housing standards; providing employment supports to 1,500 individuals with OUD/STIMUD; and supporting the delivery of at least 60 weekly mutual aid groups inclusive of individuals taking MOUD.
Overall, KY proposes to serve 103,200 individuals in year 1 and 184,800 in year 2, for an unduplicated total of 288,000 individuals over the course of the grant. Through the 2022 SOR, KORE will reduce overdose death as well as unmet harm reduction, treatment, and recovery support needs in the Commonwealth of KY.
Funding Goals
ADDRESSING THE OPIOID ABUSE CRISIS WITHIN SUCH STATES, USED FOR CARRYING OUT ACTIVITIES THAT SUPPLEMENT ACTIVITIES PERTAINING TO OPIOIDS UNDERTAKEN BY THE STATE AGENCY RESPONSIBLE FOR ADMINISTERING THE SUBSTANCE ABUSE PREVENTION AND TREATMENT BLOCK GRANT UNDER SUBPART II OF PART B OF TITLE XIX OF THE PUBLIC HEALTH SERVICE ACT (42 U.S.C. 300X21 ET SEQ.), AND TRIBES AND TRIBAL ORGANIZATIONS TO ADDRESS THE OPIOID CRISIS WITHIN THEIR COMMUNITIES.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Frankfort,
Kentucky
406012321
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 09/29/24 to 09/29/25 and the total obligations have increased 452% from $13,230,000 to $73,076,257.
Kentucky Cabinet For Health & Family Services was awarded
KY Opioid Response Effort: Prevention, Treatment & Recovery
Project Grant H79TI085782
worth $73,076,257
from the Division of Grants Management in September 2022 with work to be completed primarily in Frankfort Kentucky United States.
The grant
has a duration of 3 years and
was awarded through assistance program 93.243 Substance Abuse and Mental Health Services Projects of Regional and National Significance.
The Project Grant was awarded through grant opportunity State Opioid Response Grants.
Status
(Complete)
Last Modified 1/21/25
Period of Performance
9/30/22
Start Date
9/29/25
End Date
Funding Split
$73.1M
Federal Obligation
$0.0
Non-Federal Obligation
$73.1M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for H79TI085782
Transaction History
Modifications to H79TI085782
Additional Detail
Award ID FAIN
H79TI085782
SAI Number
H79TI085782-2605796618
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
State Government
Awarding Office
75SAMH SAMHSA DIVISION OF GRANTS MANAGEMENT
Funding Office
75MT00 SAMHSA CENTER FOR SUBSTANCE ABUSE TREATMENT
Awardee UEI
LECJQDCLHVE5
Awardee CAGE
1M3S5
Performance District
KY-01
Senators
Mitch McConnell
Rand Paul
Rand Paul
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| Substance Abuse Treatment, Substance Abuse and Mental Health Administration, Health and Human Services (075-1364) | Health care services | Grants, subsidies, and contributions (41.0) | $73,076,257 | 100% |
Modified: 1/21/25